Mitsubishi Ufj Trust & Banking Corp Recursion Pharmaceuticals, Inc. Transaction History

Mitsubishi Ufj Trust & Banking Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$7.35 - $10.05 $217,854 - $297,882	-29,640 Reduced 10.96%	240,720 $1.81 Million
Q1 2024 May 10, 2024	SELL	$9.13 - $15.52 $284,216 - $483,137	-31,130 Reduced 10.33%	270,360 $2.7 Million
Q4 2023 Feb 09, 2024	SELL	$5.09 - $10.79 $244,218 - $517,704	-47,980 Reduced 13.73%	301,490 $2.97 Million
Q3 2023 Nov 09, 2023	SELL	$6.59 - $15.86 $59,705 - $143,691	-9,060 Reduced 2.53%	349,470 $2.67 Million
Q2 2023 Aug 08, 2023	SELL	$4.56 - $9.94 $40,401 - $88,068	-8,860 Reduced 2.41%	358,530 $2.68 Million
Q3 2022 Nov 10, 2022	SELL	$7.83 - $13.6 $46,980 - $81,600	-6,000 Reduced 1.61%	367,390 $3.91 Million
Q4 2021 Feb 09, 2022	SELL	$16.14 - $21.86 $403,984 - $547,155	-25,030 Reduced 6.28%	373,390 $6.4 Million
Q3 2021 Nov 12, 2021	BUY	$19.03 - $41.33 $7.58 Million - $16.5 Million	398,420 New	398,420 $9.17 Million

286

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.12B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.